Follow the people · Insider
Thomas Zindrick
Thomas Zindrick files insider transactions with the SEC as a president and ceo of Genelux (GNLX). We hold 4 disclosed purchases and sales filed since 2 May 2023, 2 of them in the last 90 days.
- Files forGNLX
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure2 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 February 2023 — 31 August 2026President and CEO · Genelux (GNLX)30 Form 4 lines · source: SEC Form 4
Everything they disclosed
30 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 34,463 shares of GeneluxSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- ▼ sold on the open market 3,023 shares of GeneluxSEC Form 44 August 2026Common Stock · traded 4 August 2026 · filed 4 August 2026
- was granted 730,601 shares of GeneluxSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 2,798 shares of GeneluxSEC Form 412 May 2026Common Stock · traded 11 May 2026 · filed 12 May 2026
- ▼ sold on the open market 3,582 shares of GeneluxSEC Form 426 March 2026Common Stock · traded 24 March 2026 · filed 26 March 2026
- ▼ sold on the open market 3,582 shares of GeneluxSEC Form 426 March 2026Common Stock · traded 24 March 2026 · filed 26 March 2026
- ▼ sold on the open market 12,673 shares of GeneluxSEC Form 411 December 2025Common Stock · traded 21 August 2025 · filed 11 December 2025
- ▼ sold on the open market 4,509 shares of GeneluxSEC Form 411 December 2025Common Stock · traded 17 November 2025 · filed 11 December 2025
- returned to the issuer 925,000 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- was granted 925,000 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- returned to the issuer 157,372 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- was granted 157,372 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- returned to the issuer 23,568 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- was granted 23,568 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- returned to the issuer 250,000 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- was granted 250,000 shares of Genelux (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 1 September 2025 · filed 3 September 2025
- was granted 478,800 shares of Genelux (a derivative holding)SEC Form 429 August 2025Stock Option (Right to Buy) · traded 27 August 2025 · filed 29 August 2025
- was granted 361,200 shares of GeneluxSEC Form 429 August 2025Common Stock · traded 27 August 2025 · filed 29 August 2025
- ▼ sold on the open market 10,764 shares of GeneluxSEC Form 413 May 2025Common Stock · traded 12 May 2025 · filed 13 May 2025
- was granted 30,339 shares of GeneluxSEC Form 417 April 2025Common Stock · traded 14 March 2025 · filed 17 April 2025
- was granted 183,000 shares of Genelux (a derivative holding)SEC Form 420 December 2024Stock Option (right to buy) · traded 18 December 2024 · filed 20 December 2024
- was granted 134,500 shares of GeneluxSEC Form 420 December 2024Common Stock · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 14,315 shares of GeneluxSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- was granted 8,320 shares of GeneluxSEC Form 48 July 2024Common Stock · traded 19 February 2024 · filed 8 July 2024
- was granted 26,264 shares of GeneluxSEC Form 48 July 2024Common Stock · traded 14 March 2024 · filed 8 July 2024
- ▲ bought on the open market 200,000 shares of Genelux (a derivative holding)SEC Form 47 June 2024Common Stock Warrant (Right to Buy) · traded 29 May 2024 · filed 7 June 2024
- ▲ bought on the open market 200,000 shares of GeneluxSEC Form 47 June 2024Common Stock · traded 29 May 2024 · filed 7 June 2024
- was granted 250,000 shares of Genelux (a derivative holding)SEC Form 415 September 2023Stock Option (right to buy) · traded 11 September 2023 · filed 15 September 2023
- ▼ sold on the open market 8,349 shares of GeneluxSEC Form 422 August 2023Common Stock · traded 18 August 2023 · filed 22 August 2023
- was granted 23,000 shares of GeneluxSEC Form 42 May 2023Common Stock · traded 27 February 2023 · filed 2 May 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.